Exaggerated QT prolongation after cardioversion of atrial fibrillation
- 1 August 1999
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (2), 396-401
- https://doi.org/10.1016/s0735-1097(99)00226-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or FlutterJournal of the American College of Cardiology, 1997
- Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidineJournal of the American College of Cardiology, 1995
- A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study of Dofetilide in Patients with Inducible Sustained Ventricular TachyarrhythmiasJournal of Cardiovascular Electrophysiology, 1995
- Torsade de pointes complicating drug treatment of low‐malignant forms of arrhythmia: Four case reportsClinical Cardiology, 1994
- Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in ManPacing and Clinical Electrophysiology, 1993
- Sotalol-induced torsade de pointes: management with magnesium infusionPublished by Oxford University Press (OUP) ,1992
- Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectorisThe American Journal of Cardiology, 1992
- Plasma Atrial Natriuretic Peptide, Aldosterone, and Plasma Renin Activity Responses to Gradual Changes in Dietary Sodium IntakeAmerican Journal of Hypertension, 1990
- A New Method for Constant Plasma Drug Concentrations: Application to LidocaineAnnals of Internal Medicine, 1984
- Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.Heart, 1970